Skip to main content
. 2015 Sep 24;6(32):32774–32789. doi: 10.18632/oncotarget.5192

Figure 7. Treating Hs578Ts(i)8 cells with miR-134-enriched EVs substantially increases the anti-proliferative effects of anti-Hsp90 compounds, 17-AAG and PU-H71.

Figure 7

A. Treating Hs578Ts(i)8 cells with miR-134-enriched EVs increases cellular sensitivity to 17-AAG compared to the effects of NC-mimic EVs, analysed using acid phosphatase assay. B. Similarly, treating Hs578Ts(i)8 cells with miR-134-enriched EVs increases cellular sensitivity to PU-H71 compared to the effects of NC-mimic EVs, determined using acid phosphatase assay. Graphs represent triplicate biological repeats, each including three technical repeats, displayed as n = 3 mean ± SEM, where *p < 0.05, **p < 0.01, ***p < 0.001.